Fujimoto M - Search Results

1

Dihydroartemisinin inhibits melanoma migration and metastasis by affecting angiogenesis.

Li Z, Zhang Q, Zhang X, Jin Q, Yue Q, Li N, Liu H, Fujimoto M, Jin G. Li Z, et al. Among authors: fujimoto m. Phytother Res. 2023 Nov 19. doi: 10.1002/ptr.8065. Online ahead of print. Phytother Res. 2023. PMID: 37982352

2

Neonatal skin dysbiosis to infantile atopic dermatitis: Mitigating effects of skin care.

Aoyama R, Nakagawa S, Ichikawa Y, Inohara N, Yamazaki Y, Ito T, Sugihira T, Kono M, Akiyama M, Takahashi H, Takaya A, Ichikawa F, Nakano T, Tanaka S, Koyano Y, Fujimoto M, Núñez G, Shimojo N, Nakamura Y. Aoyama R, et al. Among authors: fujimoto m. Allergy. 2024 Jun;79(6):1618-1622. doi: 10.1111/all.16095. Epub 2024 Mar 9. Allergy. 2024. PMID: 38459797 No abstract available.

3

(S)-(-)-blebbistatin O-benzoate has the potential to improve atopic dermatitis symptoms in NC/Nga mice by upregulating epidermal barrier function and inhibiting type 2 alarmin cytokine induction.

Sahara S, Ueno A, Wakita N, Iwai M, Uda J, Nakaoji K, Hamada K, Maeda A, Kaneda Y, Fujimoto M. Sahara S, et al. Among authors: fujimoto m. PLoS One. 2024 May 7;19(5):e0302781. doi: 10.1371/journal.pone.0302781. eCollection 2024. PLoS One. 2024. PMID: 38713650 Free PMC article.

4

Single-cell transcriptomic profiling of lung fibroblasts in a bleomycin-induced systemic sclerosis mouse model.

Maekawa A, Ueda-Hayakawa I, Shimbo T, Yamazaki S, Ouchi Y, Kitayama T, Tamai K, Fujimoto M. Maekawa A, et al. Among authors: fujimoto m. Biochem Biophys Res Commun. 2024 Dec 31;741:151017. doi: 10.1016/j.bbrc.2024.151017. Epub 2024 Nov 18. Biochem Biophys Res Commun. 2024. PMID: 39608052

5

Distribution of shagreen patches and fibrous cephalic plaques in patients with tuberous sclerosis complex: A retrospective cohort study.

Takahashi A, Hattori S, Sakai E, Yang L, Katayama I, Fujimoto M, Wataya-Kaneda M. Takahashi A, et al. Among authors: fujimoto m. J Am Acad Dermatol. 2024 Apr;90(4):849-852. doi: 10.1016/j.jaad.2023.11.061. Epub 2023 Dec 15. J Am Acad Dermatol. 2024. PMID: 38104779 No abstract available.

6

Histological analysis of psoriasiform eruption associated with myelin oligodendrocyte glycoprotein antibody-associated disease.

Itoi-Ochi S, Kurosaki Y, Ota A, Miyazaki A, Hosokawa A, Nakano M, Takahashi T, Umegaki-Arao N, Fujimoto M. Itoi-Ochi S, et al. Among authors: fujimoto m. JAAD Case Rep. 2024 Feb 10;46:1-4. doi: 10.1016/j.jdcr.2023.12.026. eCollection 2024 Apr. JAAD Case Rep. 2024. PMID: 38445191 Free PMC article. No abstract available.

7

Non-protuberant Lesions and Diagnostic Delays in Dermatofibrosarcoma Protuberans: A Single Institutional Retrospective Analysis.

Akome J, Ishitsuka Y, Tanemura A, Kubo T, Fujimoto M. Akome J, et al. Among authors: fujimoto m. Acta Derm Venereol. 2024 Sep 24;104:adv41234. doi: 10.2340/actadv.v104.41234. Acta Derm Venereol. 2024. PMID: 39315625 Free PMC article. No abstract available.

8

Significant Role of Autophagy in Melanosomal Degradation of Dermal Macrophages: Therapeutic Insight Regarding Hyperpigmentation with Uncertain Etiology.

Takiguchi K, Yokoi K, Murase D, Yokota M, Kawabata K, Takahashi Y, Minami S, Nakamura S, Yoshimori T, Watanabe R, Fujimoto M, Tanemura A. Takiguchi K, et al. Among authors: fujimoto m. J Invest Dermatol. 2024 Sep 25:S0022-202X(24)02151-1. doi: 10.1016/j.jid.2024.09.007. Online ahead of print. J Invest Dermatol. 2024. PMID: 39332604 No abstract available.

9

Sex-based differences in neuropsychiatric symptoms are due to estradiol/ERα-dependent transcriptional regulation via the modulation of steroid levels by sirolimus.

Koike-Kumagai M, Fujimoto M, Wataya-Kaneda M. Koike-Kumagai M, et al. Among authors: fujimoto m. Pharmacol Biochem Behav. 2024 Dec;245:173875. doi: 10.1016/j.pbb.2024.173875. Epub 2024 Sep 6. Pharmacol Biochem Behav. 2024. PMID: 39245213

10

Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years.

Yokozeki H, Murota H, Matsumura T, Komazaki H; Nemolizumab-JP11 Study Group. Yokozeki H, et al. Br J Dermatol. 2024 Jul 16;191(2):200-208. doi: 10.1093/bjd/ljae131. Br J Dermatol. 2024. PMID: 38629497 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,525 results

Search Page

Filters